ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney"

  • 2021 American Transplant Congress

    Long-Term Outcomes in Older Kidney Transplant Recipients from Older Donors

    E. Cuadrado-Payán, E. Montagud-Marrahi, J. Casals-Urquiza, J. del Risco-Zevallos, D. Cucchiari, P. Ventura-Aguiar, I. Revuelta, G. Piñeiro, N. Esforzado, F. Cofan, J. Ugalde, J. Campistol, F. Oppenheimer, J. Torregrosa, F. Diekmann

    Nephrology and Kidney Transplantation, Hospital Clínic de Barcelona, Barcelona, Spain

    *Purpose: The age of patients referred for kidney transplantation has increased progressively. However, the precise influence of age on hard outcomes after transplantation is controversial*Methods:…
  • 2021 American Transplant Congress

    Pill Burden in Belatacept versus Tacrolimus-Based Immunosuppression

    S. Gattis, L. Lakhani, A. Basu

    Emory Healthcare, Atlanta, GA

    *Purpose: Medication non-adherence is a major barrier amongst renal transplant recipients, and improvement can be seen after reduction in pill burden. Belatacept versus tacrolimus-based immunosuppression…
  • 2021 American Transplant Congress

    Bortezomib for Antibody-Mediated Rejection of Renal Transplant in Youth

    L. Galea, J. Hewlett, J. Savant, S. Lopez, S. Amaral, B. Viteri

    The Children’s Hospital of Philadelphia, Philadelphia, PA

    *Purpose: The purpose of the study was to examine preliminary efficacy and tolerability of bortezomib, a protease inhibitor, in treatment-refractory antibody mediated rejection (AMR) in…
  • 2021 American Transplant Congress

    Prostate Cancer Mortality is Not Worse Among Kidney Transplant Recipients Compared to Dialysis Patients

    N. Sarabu1, W. Dong2, S. M. Koroukian2

    1University Hospital Cleveland Medical Center, Cleveland, OH, 2Case Western Reserve University, Cleveland, OH

    *Purpose: Recent recommendations from expert panel of American Society of Transplantation (AST) state that most patients with prostate cancer (PCa) do not need to wait…
  • 2021 American Transplant Congress

    COVID-19 in the Kidney Transplant Waitlist Population

    A. C. Johnson1, C. P. Larsen1, H. Gebel2, R. Bray2

    1Surgery, Emory University, Atlanta, GA, 2Pathology, Emory University, Atlanta, GA

    *Purpose: Through banked serum samples from transplant candidates across Georgia, we characterize the prevalence, timing, and duration of SARS-CoV-2 seropositivity and investigate the impact on…
  • 2021 American Transplant Congress

    Contribution of T-bet Expressing CD27+ CD21- Activated Memory B Cells Poised for Plasma Cell Differentiation to Antibody-mediated Rejection of Kidney Transplants

    K. Louis1, E. Bailly1, C. Macedo1, B. Ramaswami1, X. Gu1, G. Chalasani1, A. Zeevi1, P. Randhawa1, H. Singh2, C. Lefaucheur3, D. Metes1

    1Surgery, University of Pittsburgh, Pittsburgh, PA, 2Center for Systems immunology, Department of Immunology, University of Pittsburgh, Pittsburgh, PA, 3Human Immunology and Immunopathology, INSERM U976, Paris, France

    *Purpose: Alloimmunity triggered by donor-specific antibodies (DSAs) and ensuing development of antibody-mediated rejection (ABMR) are detrimental to organ transplants. Yet, the cellular states underlying B…
  • 2021 American Transplant Congress

    The Australian and New Zealand Living Kidney Donor Profile Index

    G. L. Irish1, S. Chadban1, N. Boudville2, S. B. Campbell3, J. Kanellis4, P. A. Clayton1

    1Australian and New Zealand Dialysis and Transplant Registry, South Australian Health and Medical Research Institute, Adelaide, Australia, 2Medical School, University of Western Australia, Perth, Australia, 3Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia, 4Department of Nephrology, Monash Health, Melbourne, Australia

    *Purpose: Risk scores may aid risk quantification and decision-making in kidney transplantation. The Living Kidney Donor Profile Index (LKDPI) was developed to choose between living…
  • 2021 American Transplant Congress

    Nomogram of Quantity of Peripheral Cxcr5+Cd8+ T Cells, Aims to Predict Risk of De Novo Dsa in First-time Kidney Transplant Recipients

    J. Zimmerer1, M. Abdel-Rasoul2, G. Bumgardner1

    1OSU, Columbus, OH, 2Center for Biostatistics, OSU, Columbus, OH

    *Purpose: We recently reported that peripheral CXCR5+CD8+ T cells are inversely associated with the risk of developing de novo DSA (dnDSA) in the first year…
  • 2021 American Transplant Congress

    Effect of Donor Glomerulosclerosis and Interstitial Fibrosis/Tubular Atrophy (IFTA) on Kidney Graft Survival: A Single Organ Procurement Organization (OPO) Data

    P. Homkrailas1, M. Hussain1, G. M. Danovitch1, K. Wheeler2, S. Bunnapradist1

    1Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, 2OneLegacy, Los Angeles, CA

    *Purpose: The kidneys of deceased donors are often biopsied to evaluate transplant organ quality. A high percentage of GS is a leading cause of kidney…
  • 2021 American Transplant Congress

    Modifiable Barriers in Decision Making Around Living Donor Kidney Transplantation – A Rapid Scoping Review to Guide (DEAL-KD) Study

    A. Ahmed1, A. Winterbottom1, S. Ahmed2, J. Stoves3, S. Daga1

    1Leeds Teaching Hospitals Trust, Leeds, United Kingdom, 2Division of Psychological and social Medicine, University of Leeds, Leeds, United Kingdom, 3Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom

    *Purpose: Living donor kidney transplantation (LDKT) is the optimal modality of renal replacement therapy for patients with advanced renal disease; associated with superior recipient and…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 101
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences